Sample Request Form

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

news

From The Blog

Intranasal epinephrine for anaphylaxis looks promising in early study

Steve Duffy - MPRAllergies
July 21, 2018

Preliminary results from INSYS Therapeutics are showing advances in their new intranasal epinephrine, with a similar bioavailability to the popular intramuscular EpiPen. President and CEO of INSYS, Saeed Motahari commented: "Given that epinephrine is on the FDA shortage list, we look forward to working closely with the Agency to determine the optimal path to making this investigational novel drug delivery system available."

Get the full story here.